If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,400 Today
Unusual Options Activity: WFC, CCL and Others Attract Market Bets, WFC V/OI Ratio Reaches 164.4
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Is Favoured by Institutional Owners Who Hold 68% of the Company
Express News | North Dakota Judge Overturns State's Abortion Ban, Making Abortion Legal In The State
Teva Pharmaceutical Industries Options Spot-On: On September 11th, 96,660 Contracts Were Traded, With 657.88K Open Interest
Teva to Present at the Bank of America 2024 Global Healthcare Conference
Unusual Options Activity: CARR, CPNG and Others Attract Market Bets, CARR V/OI Ratio Reaches 128.4
UnitedHealth Follows Competitors, Replaces Humira With Lower-Cost Biosimilars
Medincell Mandates ROTHSCHILD MARTIN MAUREL to Manage Its Liquidity Contract
Showdown at the peak! The first debate of the US election between Hart and Trump has come to an end. Who won, Trump or Harris?
On September 11th, from 9:00 to 10:45 Beijing time, the presidential candidates in the United States - former President Trump and current Vice President Harris - held a televised debate for the US presidential election. This was also the first face-to-face confrontation between the two candidates. In this debate, the two candidates discussed various issues, including the economy, abortion rights, immigration, the Israeli-Palestinian conflict, the Russia-Ukraine conflict, the Afghanistan issue, and climate change.
Teva Announces $80M Settlement To Baltimore: City Continues Opioid Litigation Against Other Companies
Sector Update: Health Care Stocks Rise in Afternoon Trading
UnitedHealth Joins Cigna, CVS in Removing AbbVie's Humira From Formularies: Report
Teva Facing EU Fine for Disparaging Copaxone Rival: Report
Teva Pharma Set to Be Hit With Antitrust Fine in EU, Bloomberg Reports
Express News | Teva Set To Be Fined By EU Antitrust Regulators In Coming Weeks For Disparaging Rival Multiple Sclerosis Medicine
Express News | Apple Announces New Sleep Apnea Features On Apple Watch; Stocks With The Same Technology See Volume
Jefferies Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $23
UBS Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $26
JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability